Truist Financial Increases Exponent (NASDAQ:EXPO) Price Target to $100.00

Exponent (NASDAQ:EXPO) had its target price boosted by Truist Financial from $95.00 to $100.00 in a report issued on Monday, Benzinga reports. They currently have a buy rating on the business services provider’s stock.

Separately, StockNews.com upgraded Exponent from a sell rating to a hold rating in a research note on Monday, March 4th.

Exponent Stock Down 0.1 %

EXPO opened at $91.85 on Monday. The firm’s 50 day moving average is $80.53 and its 200-day moving average is $81.88. Exponent has a 52-week low of $64.61 and a 52-week high of $102.72. The firm has a market capitalization of $4.65 billion, a P/E ratio of 46.39 and a beta of 0.68.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The business had revenue of $137.21 million during the quarter, compared to analyst estimates of $125.98 million. During the same period last year, the business earned $0.56 EPS. The business’s revenue was up 6.6% on a year-over-year basis. Equities analysts expect that Exponent will post 1.92 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be issued a $0.28 dividend. The ex-dividend date is Friday, June 7th. This represents a $1.12 annualized dividend and a yield of 1.22%. Exponent’s dividend payout ratio is presently 56.57%.

Insiders Place Their Bets

In other news, insider Eric Guyer sold 1,650 shares of the stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $92.58, for a total transaction of $152,757.00. Following the transaction, the insider now owns 1,846 shares of the company’s stock, valued at $170,902.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Exponent

Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Exponent by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 4,995,605 shares of the business services provider’s stock valued at $439,813,000 after purchasing an additional 19,795 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its stake in Exponent by 9.5% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,685,472 shares of the business services provider’s stock worth $401,076,000 after acquiring an additional 408,295 shares during the period. Conestoga Capital Advisors LLC lifted its holdings in Exponent by 9.6% in the first quarter. Conestoga Capital Advisors LLC now owns 2,687,351 shares of the business services provider’s stock worth $222,217,000 after acquiring an additional 236,050 shares during the last quarter. Geneva Capital Management LLC lifted its holdings in Exponent by 10.4% in the fourth quarter. Geneva Capital Management LLC now owns 1,558,189 shares of the business services provider’s stock worth $137,183,000 after acquiring an additional 146,778 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in Exponent by 11.4% in the third quarter. Ameriprise Financial Inc. now owns 693,259 shares of the business services provider’s stock valued at $59,343,000 after acquiring an additional 71,074 shares during the period. 92.37% of the stock is currently owned by institutional investors.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.